Skip to content
Saturday 29 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,569.99
+0.77%
CAC 40
8,401.18
+0.98%
STOXX 50
6,485.67
+0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE

Businesswire

  • Spring into Smarter Home Protection: EZVIZ Launches Standout Deals for the Amazon Spring Sale

    March 10, 2026

    As the new season brings longer days and fresh beginnings, EZVIZ is turning up the excitement with a lineup of irresistible offers during the Amazon Spring Sale. Known for delivering easy-to-use smart security products, EZVIZ is giving households the perfect opportunity to refresh their home protection with technology designed for modern living. This press release [...]

  • Bregal Sphere and Imperative Partner With Ambition to Deploy up to $500 Million Into Global Nature Restoration Projects

    March 10, 2026

    Bregal Sphere, part of Bregal Investments, today announced a strategic partnership with Imperative, providing financing to accelerate the development of its global pipeline of high-quality ecosystem restoration projects. As a leading institutional natural capital investor, Bregal Sphere partners with best-in-class developers to deliver large-scale carbon removal projects that generate meaningful impacts for nature, climate, and [...]

  • InXpress Completes 100,000 Specialist Deliveries as E-Commerce Reshapes Franchise Logistics

    March 10, 2026

    Global franchise network unlocks specialist delivery capabilities through TEG platform integration

  • C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology

    March 10, 2026

    C-Further to advance its first two bespoke paediatric cancer therapeutics in collaboration with leading global academic and industry investigators Selected programmes to potentially address multiple children’s cancers including Ewing sarcoma, bone sarcoma, medulloblastoma and acute myeloid leukaemia Additional C-Further programmes to be announced in 2026

  • Nextdoor Launches AI-Powered Click Optimisation to Propel Hyperlocal Advertising

    March 10, 2026

    New advanced tools boost ROI for advertisers, including Verisure, delivering four times more clicks for the same budget

  • Amentum-led Joint Venture selected for $112 Million Clean-up at Four European Nuclear Research Sites

    March 10, 2026

    A joint venture led by Amentum (NYSE: AMTM) has won a new framework contract as the lead decommissioning and waste management contractor for nuclear research sites in four European countries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310491705/en/ Under the $112 million (€95.7 million) contract, awarded by the European Commission Joint Research [...]

  • VIPR Announces Strategic Engagement with Aon to Transform Delegated Authority Operations

    March 10, 2026

    Multi-year engagement to deliver intelligent automation and operational clarity across global reinsurance platform

  • Operio Group Named Distributor for Schaefer Technologies in the United Kingdom and European Union

    March 9, 2026

    Operio Group has signed a distribution agreement with Schaefer Technologies, a manufacturer of semi-automatic encapsulation equipment. Operio Group, a holding company building a global group of brands serving the solid dose manufacturing industry, will be the official distributor of Schaefer Technologies’ products in the United Kingdom and the European Union. Schaefer Technologies develops semi-automatic capsule [...]

  • Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy

    March 9, 2026

    Coramitug is a potential first-in-class amyloid depleter antibody for the treatment of ATTR amyloidosis with cardiomyopathy1-3 Prothena has now earned $150 million to date of the $1.2 billion total eligible milestone payments from Novo Nordisk

  • ResultsCX Appoints Gautam Thakkar as Chief Executive Officer

    March 9, 2026

    ResultsCX, a provider of Customer Experience Management (CXM) services to leading global companies including Fortune 100 and FTSE 250 organizations, today announced the appointment of Gautam Thakkar as Chief Executive Officer. Thakkar will also join the company’s Board of Directors. Thakkar brings more than three decades of global leadership experience in business services, with a [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 135
  • Page 136
  • Page 137
  • Page 138
  • Page 139
  • …
  • Page 229
  • Next

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Jamie Vardy bags Bundesliga rights as he steps up streaming war with Neville and Lineker

  • Lloyds Bank and Halifax users unable to use app in latest outage

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook